Skip to main content

Nonprofit · EIN 13-1772100

NATIONAL PHARMACEUTICAL COUNCIL INC

Tax-exempt · WASHINGTON, DC 20006

Financials

$11M$9.1M2023$9.4M$10.5M2024$10.9M$12.6M2025
Revenue Expenses · by fiscal year end
Financials of NATIONAL PHARMACEUTICAL COUNCIL INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$10,925,821$12,552,394-$1,626,573$23,057,598$7,091,397$15,966,201
December 31, 2024990$9,421,713$10,511,828-$1,090,115$24,022,903$6,496,790$17,526,113
December 31, 2023990$10,954,709$9,101,142$1,853,567$23,403,513$4,783,906$18,619,607
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$0
Program service revenue
$9,400,000
Investment income
$1,425,444
Net gain from sales of assets
$742,028
Other revenue
$100,377

Expenses

Grants and similar amounts paid
$0
Compensation of officers, directors and key employees
$3,074,799
Other salaries and wages
$2,000,195
Salaries, compensation and benefits (total)
$6,341,438
Professional fundraising fees
$0
Legal fees
$117,412
Accounting fees
$86,104
Occupancy
$320,947
Travel
$232,784
Depreciation
$85,466

Balance sheet and other

Total assets, start of year
$24,022,903
Total assets, end of year
$23,057,598
Total liabilities, end of year
$7,091,397
Net assets, end of year
$15,966,201
Land, buildings and equipment
$137,200
Publicly traded securities
$13,286,240
Net assets without donor restrictions
$15,966,201
Gross receipts
$14,125,819
Employees
18
Volunteers
0
Year formed
1953
State of legal domicile
NY

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
JOHN O'BRIENPRESIDENT, CEO
Trustee or director, Officer
40$1,800,553$32,677
JONATHAN CAMPBELLCHIEF SCIENCE OFFICER
Officer
40$529,587$51,467
MICHAEL PRATTCHIEF COMMUNICATIONS OFFIC
Officer
40$379,511$44,333
KIMBERLY WESTRICHCHIEF STRATEGY OFFICER
Officer
40$365,147$51,822
KENNETH FINEGOLDSR VP OF RESEARCH & POLICY
Highest-paid employee
40$280,753$43,483
JULIE PATTERSONSENIOR DIRECTOR AND NPC EN
Highest-paid employee
40$231,696$38,968
TANYA BAILEYCHIEF OF STAFF
Highest-paid employee
40$209,627$31,011
JACQUELYN MCRAEVP OF POLICY AND EXTERNAL AFFAIRS
Highest-paid employee
40$228,946$11,475
KATHERINE LOVROSR. DIRECTOR ALLIANCE DEVELOPMENT
Highest-paid employee
40$199,995$17,839
JEN NORTONCHAIR
Trustee or director, Officer
1$0$0
REKHA RAMESHVICE CHAIR
Trustee or director, Officer
1$0$0
JUSTIN MCCARTHYDIRECTOR
Trustee or director
1$0$0
RICK DUDEKDIRECTOR
Trustee or director
1$0$0
PATTY FRITZDIRECTOR
Trustee or director
1$0$0
KEVIN HERNDIRECTOR
Trustee or director
1$0$0
14 more people on this return
NameTitleHours / weekCompensation
RUTH HOFFMANDIRECTOR
Trustee or director
1$0
CHRIS LEIBMANDIRECTOR
Trustee or director
1$0
TERRI STEWARTDIRECTOR
Trustee or director
1$0
TRENT MCLAUGHLINDIRECTOR
Trustee or director
1$0
RYAN MUNAFODIRECTOR
Trustee or director
1$0
LANCE PIECORODIRECTOR
Trustee or director
1$0
COURTNEY PIRONDIRECTOR
Trustee or director
1$0
KATE ROBINSONDIRECTOR
Trustee or director
1$0
BRUCE WILSONTREASURER
Trustee or director, Officer
1$0
VALERIE REYNOLDSDIRECTOR
Trustee or director
1$0
SULABHA RAMACHANDRANDIRECTOR
Trustee or director
1$0
MIKE VALENTADIRECTOR
Trustee or director
1$0
STEVEN PIERIDIRECTOR
Trustee or director
1$0
CHRISTINE MARSHIMMEDIATE-PAST CHAIR
Trustee or director
1$0
990 for the year ended December 31, 2024: 26 people
NameTitleHours / weekCompensationOther / benefits
JOHN O'BRIENPRESIDENT, CEO
Trustee or director, Officer
40$1,671,647$46,228
JONATHON CAMPBELLCHIEF SCIENCE OFFICER
Officer
40$548,871$47,575
KIMBERLY WESTRICHCHIEF STRATEGY OFFICER
Trustee or director, Officer
40$378,597$45,325
MICHAEL PRATTCHIEF COMMUNICATIONS OFFIC
Officer
40$374,382$25,537
JULIE PATTERSONSENIOR DIRECTOR AND NPC ENTERPRISE LAB DIRECTOR
Highest-paid employee
40$217,492$30,328
TANYA BAILEYHEAD OF MEMBERSHIP AND MEE
Highest-paid employee
40$179,799$26,780
KATHERINE LOVROSR. DIRECTOR ALLIANCE DEVELOPMENT
Highest-paid employee
40$181,428$14,178
TYLER WAGNERASSOCIATE DIRECTOR OF RESEARCH
Highest-paid employee
40$149,082$25,683
JAMES D MOTYKARESEARCH ASSOCIATE
Highest-paid employee
40$142,113$13,527
CHRISTINE MARSHCHAIR
Trustee or director, Officer
1$0$0
JAN HANSENVICE CHAIR
Trustee or director, Officer
1$0$0
JEREMY ALLENDIRECTOR
Trustee or director
1$0$0
RICK DUDEKDIRECTOR
Trustee or director
1$0$0
PATTY FRITZDIRECTOR
Trustee or director
1$0$0
KEVIN HERNDIRECTOR
Trustee or director
1$0$0
RUTH HOFFMANDIRECTOR
Trustee or director
1$0$0
CHRIS LIEBMANDIRECTOR
Trustee or director
1$0$0
CHRIS MANCILLDIRECTOR
Trustee or director
1$0$0
TRENT MCLAUGHLINDIRECTOR
Trustee or director
1$0$0
RYAN MUNAFODIRECTOR
Trustee or director
1$0$0
JEN NORTONDIRECTOR
Trustee or director
1$0$0
BLASINE PENKOWSKIDIRECTOR
Trustee or director
1$0$0
COURTNEY PIRONDIRECTOR
Trustee or director
1$0$0
REKHA RAMESHDIRECTOR
Trustee or director
1$0$0
KATE ROBINSONDIRECTOR
Trustee or director
1$0$0
BRUCE WILSONDIRECTOR
Trustee or director
1$0$0
990 for the year ended December 31, 2023: 30 people
NameTitleHours / weekCompensationOther / benefits
JOHN O'BRIENPRESIDENT, CEO
Trustee or director, Officer
40$1,462,383$35,532
ROBERT NORDYKEVICE PRESIDENT OF RESEARCH
Officer
40$289,469$14,499
ROCHELLE HENDERSONVICE PRESIDENT OF RESEARCH
Highest-paid employee
40$241,996$24,136
JONATHON CAMPBELLCHIEF SCIENCE OFFICER
Officer
40$237,568$19,510
MICHAEL PRATTCHIEF COMMUNICATIONS OFFICER
Officer
40$225,666$16,644
JULIE PATTERSONSENIOR DIRECTOR OF RESEARCH
Highest-paid employee
40$197,246$34,472
NICOLE BERRYDIRECTOR OF ADMINISTRATION
Highest-paid employee
40$128,580$30,811
TANYA BAILEYHEAD OF MEMBERSHIP AND MEETINGS
Highest-paid employee
40$131,901$25,294
JAMES D MOTYKARESEARCH ASSOCIATE
Highest-paid employee
40$129,894$12,089
KIMBERLY WESTRICHCHIEF STRATEGY OFFICER
Trustee or director, Officer
40$74,038$0
CHRISTINE MARSHCHAIR
Trustee or director, Officer
1$0$0
CHRISTIAN NGUYENVICE CHAIR AND TREASURER
Trustee or director, Officer
1$0$0
JIM CUROTTODIRECTOR
Trustee or director
1$0$0
SHONTELLE DODSONDIRECTOR
Trustee or director
1$0$0
CHRIS COMPISIDIRECTOR
Trustee or director
1$0$0
EDWARD FEELEYDIRECTOR
Trustee or director
1$0$0
CHRIS LEIBMANDIRECTOR
Trustee or director
1$0$0
JAN HANSENDIRECTOR
Trustee or director
1$0$0
REKHA RAMESHDIRECTOR
Trustee or director
1$0$0
BETH RADADIRECTOR
Trustee or director
1$0$0
BLASINE PENKOWSKIDIRECTOR
Trustee or director
1$0$0
COURTNEY PIRONDIRECTOR
Trustee or director
1$0$0
JEREMY ALLENDIRECTOR
Trustee or director
1$0$0
PHIL NAUGHTONDIRECTOR
Trustee or director
1$0$0
PATTY FRITZDIRECTOR
Trustee or director
1$0$0
RICK DUDEKDIRECTOR
Trustee or director
1$0$0
RUTH HOFFMANDIRECTOR
Trustee or director
1$0$0
CHRIS MANCILLDIRECTOR
Trustee or director
1$0$0
TRENT MCLAUGHLINDIRECTOR
Trustee or director
1$0$0
MOHIT MANRAODIRECTOR
Trustee or director
1$0$0

Address and contacts

Address (IRS master file)
1717 PENNSYLVANIA AVE NW STE 800, WASHINGTON, DC 20006-4665
Principal officer (990 for 2025)
JOHN MICHAEL O'BRIEN, 1717 PENNSYLVANIA AVE NW NO 800, WASHINGTON, DC 20006
Signed the 990
JOHN MICHAEL O'BRIEN, CEO
Phone
(202) 827-2100
Return prepared by
YOUNT HYDE & BARBOUR PC

Mission

TO EXPLORE, DEMONSTRATE AND COMMUNICATE - THROUGH RESEARCH, PARTNERSHIP AND EDUCATION - THE ROLE AND VALUE OF INNOVATIVE BIOPHARMACEUTICALS TO ACHIEVE BETTER PATIENT HEALTH.

990 for the year ended December 31, 2025

Program accomplishments

  • NPC FOCUSES ON RESEARCH DEVELOPMENT, INFORMATION DISSEMINATION, EDUCATION AND COMMUNICATION OF THE CRITICAL ISSUES OF EVIDENCE, INNOVATION AND THE VALUE OF MEDICINES FOR PATIENTS. ALL ACTIVITIES UNDERTAKEN BY NPC RELATED TO THESE FUNCTIONS.

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
13-1772100
Tax-exempt status
501(c)(6): Business league or chamber of commerce
Donations deductible
No
Exempt since
1955
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$23,057,598
Income (IRS master file)
$14,125,819

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025$10,925,821$12,552,394$23,057,598IRS
990December 2024$9,421,713$10,511,828$24,022,903IRS
990December 2023$10,954,709$9,101,142$23,403,513XML
990December 2022$8,284,643$10,099,912$24,620,287IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2019–––IRS
990December 2018–––IRS
990December 2017–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 13-1772100).

Questions about NATIONAL PHARMACEUTICAL COUNCIL INC

What is the EIN of NATIONAL PHARMACEUTICAL COUNCIL INC?
The employer identification number (EIN) of NATIONAL PHARMACEUTICAL COUNCIL INC is 13-1772100.
Is NATIONAL PHARMACEUTICAL COUNCIL INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(6) since 1955.
Are donations to NATIONAL PHARMACEUTICAL COUNCIL INC tax-deductible?
No. The IRS master file says contributions to it are not deductible.
Which annual return does NATIONAL PHARMACEUTICAL COUNCIL INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of NATIONAL PHARMACEUTICAL COUNCIL INC due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did NATIONAL PHARMACEUTICAL COUNCIL INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of NATIONAL PHARMACEUTICAL COUNCIL INC?
The 990 for the year ended December 31, 2025 names JOHN MICHAEL O'BRIEN.
Who are the officers and directors of NATIONAL PHARMACEUTICAL COUNCIL INC?
The 990 for the year ended December 31, 2025 lists 29 people; 9 received compensation from the organization, the highest $1,800,553 (JOHN O'BRIEN, PRESIDENT, CEO).
How much revenue does NATIONAL PHARMACEUTICAL COUNCIL INC have?
On its 990 for the year ended December 31, 2025 it reported revenue of $10,925,821, expenses of $12,552,394 and total assets of $23,057,598 at year end.

Other nonprofits in WASHINGTON

All nonprofits in WASHINGTON · District of Columbia